Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Moxifloxacin 400 Mg Fasted

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT01642485Phase 1Completed

Food and Insulin Effect on QT/QTC Interval of ECG

Showing all 1 trials

Research Network

Common Treatments

  • Moxifloxacin 400 Mg Fasted1
  • Fda Breakfast1
  • Insulin Clamp1
  • Moxifloxacin 400 Mg Fed1
  • Continental Breakfast1

Active Sponsors

  • Richmond Pharmacology Limited1

Top Investigators

Related Conditions

  • Moxifloxacin Ecg Profile In Fed And Fasted State1
  • Japanese Vs Caucasian Tqt Comparison1
  • Cpeptide Effects On The Qtqtc Interval1
  • Effects Of Different Meals On The Qtqtc Interval1

Activity Timeline